In 2013, genomic studies identified a rare polymorphism of this receptor resulting in the aminoacidic change R47H (rs75932628), whose odds ratio is almost as high as that associated with APOE4 (2.6–4.5-fold increased AD risk) [242,243]. This evidence concerns the gene APOE and Alzheimer disease.